BacTrace BioTec AG

The RACORDIAX COVID-19 antibody rapid test was developed to simultaneously analyze the current status of IgM, IgG and IgA antibodies as quickly and accurately as possible via a digital platform.
Manufactured in Germany, the CE-marked test provides a test result with 99.41% sensitivity and 99.13% specificity in just 10 minutes, using the appropriate smartphone iOS or Android RACORDIAX App.


BacTrace BioTec AG works closely with a renowned and decorated Scientific Advisory Board as well as with internationally recognized universities and scientific institutions.

  • Prof. Dr. Dr. h.c. mult. Willi Jäger, Universität Heidelberg
  • Dipl.-Ing. Manfred Opel, Brigade General a.D.
  • Prof. Dr. Valentin N. Pavlov, Bashkir State Medical University
  • Priv.-Doz. Dr. med. Michael T. Pawlik, Universität Regensburg
  • Dr. med. Sören Wagner, Harvard Medical School
  • Prof. Dr. med. Dr. h.c. mult. Wolf F. Wieland, Universität Regensburg
  • Dr. med. Hans Hermann Wörl